Catalytica Pharmaceuticals, Inc.

Catalytica Pharmaceuticals was established on August 1, 1997, an affiliate of Catalytica, Inc., with the acquisition of the former Burroughs Wellcome Co. manufacturing facility from Glaxo Wellcome, Inc. This has resulted in the unique advantage of a highly skilled workforce with an average length of tenure for development scientists, operators and technicians of 13 years, providing exceptional manufacturing and development expertise. The average management tenure is even longer. There is a culture and tradition of ownership, quality, reliability and integrity. This is where excellence begins at Catalytica Pharmaceuticals.

Activity:

- Manufacturing

Product / Technology type(s) covered:

- Pharmaceuticals / Therapeutics

Therapeutic targets:

Markets Covered

a. HeadQuarter:

b. Continent(s) active:

c. Countries active:

Corporate data:

Number of Employees:

Turnover:

Amount:	Year:	Currency:

Year founded: